NCT03257943View on ClinicalTrials.gov

A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5%

PHASE1CompletedINTERVENTIONAL
Enrollment

413

Participants

Timeline

Start Date

March 20, 2017

Primary Completion Date

June 27, 2017

Study Completion Date

August 18, 2017

Conditions
Lice; Head Lice
Interventions
DRUG

Ivermectin Lotion, 0.5%

Ivermectin Lotion, 0.5% (Taro Pharmaceuticals Inc.)

DRUG

SKLICE (ivermectin) Lotion, 0.5%

SKLICE (ivermectin) Lotion, 0.5% (Arbor Pharmaceuticals, LLC)

DRUG

Vehicle of the Test product

Vehicle for Ivermectin Lotion, 0.5% (Taro Pharmaceuticals Inc.)

Trial Locations (1)

10532

Taro Pharmaceuticals USA Inc., Hawthorne

All Listed Sponsors
lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT03257943 - A Bioequivalence Study, Comparing Two Formulations of Ivermectin Lotion, 0.5% | Biotech Hunter | Biotech Hunter